Merlin Therapeutics Inc.

King of Prussia, PA

UEI
MVKSHRPYUJ22
CAGE
9GGF5
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Woman Owned Small Business
  • Woman Owned Business
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
SAM.gov registration date
Physical address
411 Swedeland Rd, King of Prussia, PA 19406, USA
Website
merlintherapeutics.com
Founded
2022
Employees
1-10
Estimated annual revenue
$0-$1M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Merlin Therapeutics Inc.'s 2 most recent federal contract and grant awards, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
AAV-mediated delivery of the inflammasome adapter protein, ASC, as a pro-apoptotic gene therapy for schwannoma - summary… Grant · R44NS145814 National Institute of Neurological Disorders and Stroke $2,756,291
Development of a novel AAV9 gene replacement therapy for neurofibromatosis type 2 - project summary/abstract the… Grant · R41NS135883 National Institute of Neurological Disorders and Stroke $699,559

Quick answers

What is Merlin Therapeutics Inc.'s UEI?

Merlin Therapeutics Inc.'s Unique Entity ID (UEI) in SAM.gov is MVKSHRPYUJ22.

What is Merlin Therapeutics Inc.'s CAGE code?

Merlin Therapeutics Inc.'s CAGE code is 9GGF5.

What is Merlin Therapeutics Inc.'s primary NAICS code?

Merlin Therapeutics Inc.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).

Where is Merlin Therapeutics Inc. located?

Merlin Therapeutics Inc.'s physical address in SAM.gov is 411 Swedeland Rd, King of Prussia, PA 19406, USA.

Is Merlin Therapeutics Inc. registered in SAM.gov?

Yes. Merlin Therapeutics Inc.'s SAM.gov registration is active through February 18, 2027.

What is Merlin Therapeutics Inc.'s most recent federal award?

Merlin Therapeutics Inc.'s most recent federal grant award is AAV-mediated delivery of the inflammasome adapter protein, ASC, as a pro-apoptotic gene therapy for schwannoma - summary… (R44NS145814), from National Institute of Neurological Disorders and Stroke, on August 27, 2025.

On GovTribe

See Merlin Therapeutics Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login